Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Indole is a microbial metabolite produced in the human gut, primarily through the bacterial metabolism of the essential amino acid L-tryptophan. It serves as a key precursor to several uremic toxins, most notably indoxyl sulfate and indole-3-acetic acid, which accumulate in patients with impaired kidney function and contribute to systemic toxicity. In chronic kidney disease (CKD), reduced excretion leads to the accumulation of protein-bound uremic toxins (PBUTs) such as indoxyl sulfate, resulting in vascular damage, heightened morbidity and mortality, proinflammatory signaling, and oxidative stress.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Indole.